As we observed an association of PAI-1 with T2DM, but not with the degree of glycemic control, our data are coherent with previous findings and with the concept that, in T2DM, the increase in PAI-1 levels impairs fibrinolysis mainly via insulin resistance. The gene discussed is SERPINE1; the disease is Insulin resistance.